ES474900A1 - Metodo para producir nues n''-4-quinolilguanidinas n,n'-di- sustituidas para la terapia de la artritis reumatoide, os- teo-artritis y estados relacionados - Google Patents

Metodo para producir nues n''-4-quinolilguanidinas n,n'-di- sustituidas para la terapia de la artritis reumatoide, os- teo-artritis y estados relacionados

Info

Publication number
ES474900A1
ES474900A1 ES474900A ES474900A ES474900A1 ES 474900 A1 ES474900 A1 ES 474900A1 ES 474900 A ES474900 A ES 474900A ES 474900 A ES474900 A ES 474900A ES 474900 A1 ES474900 A1 ES 474900A1
Authority
ES
Spain
Prior art keywords
alkyl
substituted
trifluoromethyl
ring system
arthritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES474900A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Publication of ES474900A1 publication Critical patent/ES474900A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ES474900A 1977-11-07 1978-11-07 Metodo para producir nues n''-4-quinolilguanidinas n,n'-di- sustituidas para la terapia de la artritis reumatoide, os- teo-artritis y estados relacionados Expired ES474900A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4616677 1977-11-07

Publications (1)

Publication Number Publication Date
ES474900A1 true ES474900A1 (es) 1980-04-16

Family

ID=10440127

Family Applications (1)

Application Number Title Priority Date Filing Date
ES474900A Expired ES474900A1 (es) 1977-11-07 1978-11-07 Metodo para producir nues n''-4-quinolilguanidinas n,n'-di- sustituidas para la terapia de la artritis reumatoide, os- teo-artritis y estados relacionados

Country Status (24)

Country Link
US (1) US4293549A (OSRAM)
JP (1) JPS5473784A (OSRAM)
AT (1) AT366368B (OSRAM)
AU (1) AU517670B2 (OSRAM)
BE (1) BE871807A (OSRAM)
CA (1) CA1120929A (OSRAM)
CH (1) CH645354A5 (OSRAM)
DE (1) DE2847792A1 (OSRAM)
DK (1) DK153950C (OSRAM)
ES (1) ES474900A1 (OSRAM)
FI (1) FI69463C (OSRAM)
FR (1) FR2407930A1 (OSRAM)
GR (1) GR65010B (OSRAM)
IE (1) IE47458B1 (OSRAM)
IT (1) IT1100075B (OSRAM)
LU (1) LU80476A1 (OSRAM)
NL (1) NL7811035A (OSRAM)
NZ (1) NZ188770A (OSRAM)
PH (1) PH16296A (OSRAM)
PT (1) PT68750A (OSRAM)
SE (1) SE446267B (OSRAM)
SU (1) SU828967A3 (OSRAM)
YU (1) YU41129B (OSRAM)
ZA (1) ZA786175B (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306846B1 (en) * 1972-05-31 2001-10-23 John R. J. Sorenson Anti-inflammatory and anti-ulcer compounds and process
IT1205640B (it) * 1983-04-06 1989-03-23 Yason Srl Nuovi composti ad attivita' antiinfiammatoria,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
US4563460A (en) * 1984-01-13 1986-01-07 William H. Rorer, Inc. Quinoline and quinazoline derivatives for treating gastrointestinal motility dysfunctions
HU195487B (en) * 1985-06-04 1988-05-30 Egyt Gyogyszervegyeszeti Gyar Process for producing quinoline derivatives
DE3772301D1 (de) * 1986-08-29 1991-09-26 Pfizer 2-guanidino-4-aryl-thiazole fuer die behandlung von peptischen geschwueren.
US6100260A (en) * 1997-04-21 2000-08-08 Sumitomo Pharmaceutical Company, Limited Isoxazole derivatives
SI0928793T1 (en) * 1998-01-02 2002-10-31 F. Hoffmann-La Roche Ag Thiazole derivatives
BR9909666A (pt) 1998-03-26 2001-09-11 Japan Tobacco Inc Derivados de amida e antagonistas de nociceptina
EP1237849A1 (en) * 1999-11-05 2002-09-11 University College London Activators of soluble guanylate cyclase
US7186725B2 (en) * 2003-01-03 2007-03-06 Genzyme Corporation Anti-inflammatory compositions and methods
EP1615878B1 (en) * 2003-01-14 2012-04-04 Cytokinetics, Inc. Compounds, compositions and methods of treatment for heart failure
GB0404434D0 (en) * 2004-02-27 2004-03-31 Novartis Ag Organic compounds
EP1917244A2 (de) * 2005-08-24 2008-05-07 Abbott GmbH & Co. KG Hetaryl substituierte guanidinverbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
CN117677386A (zh) * 2021-07-23 2024-03-08 瓦伦塔有限责任公司 具有亲溶酶体和抗病毒活性的化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB889282A (en) * 1957-05-07 1962-02-14 Air Reduction Preparation of hexafluorodiethyl ether and medicinal compositions containing it
GB889262A (en) * 1959-07-03 1962-02-14 Ciba Ltd Quinoline compounds
US3159676A (en) * 1962-02-07 1964-12-01 Smith Kline French Lab Naphthyl containing guanidines
US3852293A (en) 1972-06-21 1974-12-03 Uniroyal Inc 4-phenyl-2-(3-pyridyl)-thiazole carboxamides
US4000279A (en) * 1974-10-29 1976-12-28 Armour Pharmaceutical Company Pharmaceutical preparations containing 5'-(8'-hydroxyquinolyl)guanidine compounds and methods of using same

Also Published As

Publication number Publication date
FR2407930B1 (OSRAM) 1983-03-18
US4293549A (en) 1981-10-06
FI783327A7 (fi) 1979-05-08
IE782084L (en) 1979-05-07
LU80476A1 (fr) 1979-06-15
DK493378A (da) 1979-05-08
NZ188770A (en) 1984-07-31
PT68750A (en) 1978-12-01
FI69463C (fi) 1986-02-10
CH645354A5 (de) 1984-09-28
JPS6348873B2 (OSRAM) 1988-09-30
FR2407930A1 (fr) 1979-06-01
DE2847792C2 (OSRAM) 1988-02-04
SE446267B (sv) 1986-08-25
CA1120929A (en) 1982-03-30
AU4137678A (en) 1979-05-17
AT366368B (de) 1982-04-13
IT7829514A0 (it) 1978-11-07
DK153950B (da) 1988-09-26
ZA786175B (en) 1979-10-31
YU257578A (en) 1983-01-21
PH16296A (en) 1983-09-05
SU828967A3 (ru) 1981-05-07
DK153950C (da) 1989-02-20
DE2847792A1 (de) 1979-05-10
YU41129B (en) 1986-12-31
BE871807A (fr) 1979-05-07
SE7811457L (sv) 1979-05-08
FI69463B (fi) 1985-10-31
NL7811035A (nl) 1979-05-09
IE47458B1 (en) 1984-03-21
JPS5473784A (en) 1979-06-13
ATA773278A (de) 1981-08-15
GR65010B (en) 1980-06-12
AU517670B2 (en) 1981-08-20
IT1100075B (it) 1985-09-28

Similar Documents

Publication Publication Date Title
ES474900A1 (es) Metodo para producir nues n''-4-quinolilguanidinas n,n'-di- sustituidas para la terapia de la artritis reumatoide, os- teo-artritis y estados relacionados
ES459024A1 (es) Procedimiento para la preparacion de un compuesto tetraci- clico.
DK0541550T3 (da) Nye mellemprodukter, deres fremstilling og anvendelse
ES360802A1 (es) Procedimiento para la preparacion de derivados del naftace-no.
SE7704616L (sv) Sett att framstella nya 11-desoxi-prostaglandin-fÿ2-derivat
ES467069A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-3-bencenodimetanol
ES417638A1 (es) Procedimiento para preparar oxazoles 2,4,5-trisustituidos.
ES417890A1 (es) Proceso para la preparacion de nuevos derivados del acido amidinopenicilanico y sus sales farmaceuticamente acepta- bles.
ES472276A1 (es) Un procedimiento para la preparacion de un grupo de cis-4a- aril-octahidro-1h-2-pirindinas 2-sustituidas
AU544275B2 (en) Triazololozuinazolinone derivatives
ES447751A1 (es) Procedimiento para preparar derivados de imidazolilquinazo- lina.
NO920619L (no) Oxazinobenzazolforbindelser
ES308890A1 (es) Procedimiento de fabricacion de derivados tetrafluorobencenicos
ATE75472T1 (de) Ergolinylheterocyclen.
ES448696A1 (es) Procedimiento para la preparacion de 4-fenil-imidazolinas sustituidas.
ES458021A1 (es) Procedimiento para la obtencion de derivados de acido pros- tanoico.
ES446743A1 (es) Un procedimiento para la preparacion de una sal cristalina yestable de cefalosporinas.
ES454421A1 (es) Procedimiento para preparar derivados de acetamidoxina.
ES444930A1 (es) Procedimiento para preparar triazinadionas.
ES417269A1 (es) Procedimiento para preparar derivados de imidazolidinona.
ES448995A1 (es) Procedimiento para preparar derivados de 10-(2-hidroxi-3-ami-no-propoxi)-4h-benzon4,5 ciclohetan1,2-bntiofeno.
ES2079850T3 (es) Derivados de tiazolo-isoindolinona opticamente activos, con efecto antivirico.
DK77280A (da) Heterocycliske spirosammenknyttede amidiner deres steroisomere og optiske isomere fremgangsmaade til deres fremstilling samt laegemidler indeholdende dem
ES248267A1 (es) Procedimiento para la obtencion de nuevos derivados de hidrazinas heterociclicas y sus sales
ES8303414A1 (es) Un procedimiento de preparacion de derivados de triazoloqui-nazolinona.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990201